Related references
Note: Only part of the references are listed.Introduction: Standards of Medical Care in Diabetes-2022
DIABETES CARE (2022)
Clinical Outcome and Cost-Effectiveness Analysis of CSII Versus MDI in Children and Adolescent With Type 1 Diabetes Mellitus in a Public Health Care System of China
Sicui Hu et al.
FRONTIERS IN ENDOCRINOLOGY (2021)
Reduction in Diabetic Ketoacidosis and Severe Hypoglycemia in Pediatric Type 1 Diabetes During the First Year of Continuous Glucose Monitoring: A Multicenter Analysis of 3,553 Subjects From the DPV Registry
Martin Tauschmann et al.
DIABETES CARE (2020)
State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016-2018
Nicole C. Foster et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2019)
Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort study
Araz Rawshani et al.
LANCET (2018)
EPIDEMIOLOGICAL CHARACTERISTICS, MEDICAL COST AND HEALTHCARE RESOURCE UTILIZATION OF DIABETES-RELATED COMPLICATIONS AMONG CHINESE PATIENTS WITH TYPE 2 DIABETES MELLITUS
X. Duan et al.
VALUE IN HEALTH (2018)
Association of Insulin Pump Therapy vs Insulin Injection Therapy With Severe Hypoglycemia, Ketoacidosis, and Glycemic Control Among Children, Adolescents, and Young Adults With Type 1 Diabetes
Beate Karges et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Rapidly rising incidence of Type 1 diabetes in children and adolescents aged 0-19 years in Zhejiang, China, 2007 to 2013
H. B. Wu et al.
DIABETIC MEDICINE (2016)
Impact of Sex and Age at Onset of Diabetes on Mortality From Ischemic Heart Disease in Patients With Type 1 Diabetes
Valma Harjutsalo et al.
DIABETES CARE (2014)
Validation of the IMS CORE Diabetes Model
Phil McEwan et al.
VALUE IN HEALTH (2014)
Review of Utility Values for Economic Modeling in Type 2 Diabetes
Amelie Beaudet et al.
VALUE IN HEALTH (2014)
Incidence of Type 1 Diabetes in Mexico: Data From an Institutional Register 2000-2010
Rita A. Gomez-Diaz et al.
DIABETES CARE (2012)
Age-Period-Cohort Analysis of 1990-2003 Incidence Time Trends of Childhood Diabetes in Italy The RIDI Study
Graziella Bruno et al.
DIABETES (2010)
Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation
E. Cummins et al.
HEALTH TECHNOLOGY ASSESSMENT (2010)
Effectiveness of Sensor-Augmented Insulin-Pump Therapy in Type 1 Diabetes
Richard M. Bergenstal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Health Economic Comparison Between Continuous Subcutaneous Insulin Infusion and Multiple Daily Injections of Insulin for the Treatment of Adult Type 1 Diabetes in Canada
Meaghan E. St. Charles et al.
CLINICAL THERAPEUTICS (2009)
A Cost-Effectiveness Analysis of Continuous Subcutaneous Insulin Injection versus Multiple Daily Injections in Type 1 Diabetes Patients: A Third-Party US Payer Perspective
Meaghan St Charles et al.
VALUE IN HEALTH (2009)
Continuous subcutaneous insulin infusion versus multiple daily injections of insulin - Economic comparison in adult and adolescent type 1 diabetes Mellitus in Australia
Neale Cohen et al.
PHARMACOECONOMICS (2007)
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
DM Nathan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Validation of the CORE diabetes model against epidemiological and clinical studies
AJ Palmer et al.
CURRENT MEDICAL RESEARCH AND OPINION (2004)
Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: meta-analysis of randomised controlled trials
J Pickup et al.
BMJ-BRITISH MEDICAL JOURNAL (2002)
Diabetes management in the new millennium using insulin pump therapy
BW Bode et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2002)
Continuous subcutaneous insulin infusion - A comprehensive review of insulin pump therapy
MJ Lenhard et al.
ARCHIVES OF INTERNAL MEDICINE (2001)
Share Paper
